FDA Issues Warning About Some Sleep Aids (Ambien) Containing Zolpidem

The FDA has issued a safety announcement regarding drugs containing Zolpidem (Ambien, Ambien CR, Edular and Zolpimist) that are used in the treatment of insomnia.  These drugs can impair driving and other activities that require alertness the morning after a drug has been taken.  Women may be particularly sensitive to Zolpidem.
For the complete communication from the FDA, click here.

FDA requires lower doses for Ambien, other sleep meds

 

About The Author

Laura Hack

Laura Hack

Laura Hack is a paralegal with Terrell • Hogan. She has been with the firm since 1996 and has worked primarily for Wayne Hogan. She is an experienced Paralegal with 30+ years of working in the law practice industry. Skilled in Appeals, Civil Trial Litigation Support, Torts, Trial Practice, and Pleadings.